U.S. FDA OFFICIAL SAYS AGENCY ACTIVELY EXPLORING ALL OPTIONS TO PROVIDE ACCESS TO ADDITIONAL DOSES OF COVID-19 VACCINES WHERE DATA SUGGESTS IT - ACIP MEETING